Table 1. Distribution of the rats across experimental groups.
Weight | Range | ||||||||
---|---|---|---|---|---|---|---|---|---|
Strain | Group | N | Mean | ± | SD | Min | - | Max | |
PET | |||||||||
[18F]FDG | Sprague-Dawley | Healthy | 9 | 376 | ± | 31 | 323 | - | 424 |
Wistar | Healthy | 25 | 318 | ± | 57 | 247 | - | 437 | |
[11C]Flumazenil | Wistar | Healthy | 13 | 250 | ± | 20 | 222 | - | 288 |
[11C]MeDAS | Wistar | Healthy | 15 | 260 | ± | 15 | 233 | - | 284 |
[11C]PK11195 | Sprague-Dawley | Healthy | 11 | 317 | ± | 51 | 261 | - | 395 |
Injection of saline | 10 | 298 | ± | 18 | 272 | - | 328 | ||
Wistar | Healthy | 19 | 319 | ± | 49 | 225 | - | 399 | |
Herpes encephalitis | 14 | 301 | ± | 35 | 250 | - | 350 | ||
[11C]Raclopride | Wistar | Healthy | 6 | 291 | ± | 37 | 235 | - | 350 |
SPECT | |||||||||
[99mTc]HMPAO | Wistar | Healthy | 15 | 266 | ± | 13 | 244 | - | 290 |
Total | Sprague-Dawley | 30 | 329 | ± | 48 | 261 | - | 424 | |
Wistar | 107 | 291 | ± | 47 | 222 | - | 437 |